RESPIRATORY PATHOGEN DETECTION
FDA-cleared respiratory panel provides an overall sensitivity of 95% and specificity of 99%. Rapid and accurate diagnostic testing for respiratory pathogens help identify which patients to isolate and determine antibiotic or antiviral therapy.
Each year in the US, 2 million people acquire serious bacterial infections that are resistant to one or more prescribed antibiotics, and at least 23,000 people die as a direct result of these antibiotic resistant infections.8 An estimated 55% of antibiotic prescriptions for Acute Respiratory Tract Infections are unnecessary.9 The misuse of antibiotics costs the US healthcare system over $20 billion each year.10
